公开(公告)号：US20220241331A1

公开(公告)日：2022-08-04

申请号：US17612279

申请日：2020-05-19

Applicant: Yeda Research and Development Co. Ltd.

Inventor： Yardena SAMUELS ,  Shelly KALAORA ,  Aviyah PERI ,  Nir FRIEDMAN ,  Shlomit REICH-ZELIGER ,  Erez GREENSTEIN

IPC: A61K35/17 ,  C07K14/47 ,  C07K14/725 ,  C07K14/82 ,  C12N5/0783

Abstract: A method of treating cancer in a subject is disclosed. The method comprises administering to the subject a therapeutically effective amount of T cells expressing a T cell receptor (TCR) having a CDR3 amino acid sequence selected from the group consisting of 199-210.